tiprankstipranks
Trending News
More News >
Vitura SA (FR:VTR)
:VTR
Advertisement

Vitura SA (VTR) AI Stock Analysis

Compare
2 Followers

Top Page

FR:VTR

Vitura SA

(LSE:VTR)

Rating:46Neutral
Price Target:
€6.00
▲(0.84% Upside)
The overall stock score is primarily impacted by the company's poor financial performance, characterized by declining revenues and high debt levels. Technical analysis provides a neutral outlook, while valuation concerns due to negative earnings further weigh down the score.

Vitura SA (VTR) vs. iShares MSCI France ETF (EWQ)

Vitura SA Business Overview & Revenue Model

Company DescriptionVitura SA (VTR) is a leading company in the healthcare sector, specializing in the development and distribution of innovative pharmaceutical products and medical devices. The company operates across various therapeutic areas, including oncology, cardiology, and neurology, and is committed to enhancing patient care through cutting-edge research and development. Vitura SA focuses on providing high-quality solutions that meet the needs of healthcare professionals and patients alike.
How the Company Makes MoneyVitura SA generates revenue primarily through the sale of its pharmaceutical products and medical devices to hospitals, clinics, and pharmacies. The company engages in both direct sales and partnerships with distributors to expand its market reach. Key revenue streams include prescription medications, over-the-counter products, and specialized medical equipment. Additionally, Vitura SA may earn royalties from licensing its proprietary technologies to other companies in the healthcare industry. Strategic partnerships with research institutions and healthcare providers also enhance its development capabilities and market presence, contributing to its overall earnings.

Vitura SA Financial Statement Overview

Summary
Vitura SA is facing severe financial distress with declining revenues, high debt levels, and inconsistent cash flow generation. The financial outlook is uncertain without significant improvements.
Income Statement
30
Negative
Vitura SA has experienced a significant decline in revenue from 2023 to 2024 and negative net income, indicating severe financial distress. The gross profit margin is decreasing over years. The EBIT margin is volatile with recent negative values, reflecting challenges in maintaining profitability.
Balance Sheet
40
Negative
The company's debt-to-equity ratio is concerning due to high leverage, which poses a risk to financial stability. Stockholders' equity has decreased significantly, and the equity ratio indicates declining financial health. These factors suggest potential risks if market conditions worsen.
Cash Flow
45
Neutral
Free cash flow has shown occasional growth but remains inconsistent, with recent negative trends. The operating cash flow to net income ratio is unreliable due to negative net income, which complicates cash flow management. Cash flow generation is volatile, indicating cash management challenges.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue57.87M76.61M78.02M84.92M84.88M
Gross Profit32.91M50.43M49.38M63.67M63.32M
EBITDA25.98M-166.93M23.22M45.52M54.89M
Net Income-243.00M-239.85M-4.18M36.93M16.09M
Balance Sheet
Total Assets940.47M1.40B1.62B1.66B1.55B
Cash, Cash Equivalents and Short-Term Investments13.49M11.72M18.87M57.48M62.84M
Total Debt644.20M855.10M824.85M824.06M776.73M
Total Liabilities671.57M883.93M868.77M890.52M817.80M
Stockholders Equity268.91M511.91M755.44M772.94M734.32M
Cash Flow
Free Cash Flow3.83M-17.45M-22.70M-69.37M32.41M
Operating Cash Flow12.61M12.04M-9.36M40.90M42.64M
Investing Cash Flow-2.69M-29.32M-19.47M-103.31M-9.57M
Financing Cash Flow-8.15M13.83M-13.48M57.05M-15.11M

Vitura SA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5.95
Price Trends
50DMA
5.97
Positive
100DMA
6.16
Negative
200DMA
5.94
Positive
Market Momentum
MACD
<0.01
Negative
RSI
60.35
Neutral
STOCH
55.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:VTR, the sentiment is Positive. The current price of 5.95 is above the 20-day moving average (MA) of 5.91, below the 50-day MA of 5.97, and above the 200-day MA of 5.94, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 60.35 is Neutral, neither overbought nor oversold. The STOCH value of 55.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:VTR.

Vitura SA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (56)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
56
Neutral
$13.56B12.8310.03%0.92%7.13%-12.93%
46
Neutral
€102.37M-16.98%-7.84%71.77%
€49.94M-3.43%
€3.21B13.806.44%3.94%
€6.19B12.094.93%
€641.79M-10.94%
63
Neutral
€349.07M69.53
8.39%10.30%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:VTR
Vitura SA
5.95
0.05
0.85%
GB:0DYL
Acanthe Developpement
0.31
-0.04
-11.43%
GB:0IXY
Societe Fonciere Lyonnaise SA
72.40
9.05
14.29%
GB:0OPE
Gecina
83.35
-15.61
-15.77%
GB:0IUE
Societe de la Tour Eiffel
5.04
-4.62
-47.83%
FR:INEA
Fonciere INEA
32.70
4.43
15.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 05, 2025